There is increasing clinical and laboratory interest in the measurement of both plasma
fibrinogen and fibrin D-dimer to predict arterial thrombotic events, such as cardiovascular …

There is growing evidence that fibrin d-dimer is associated with coronary and peripheral
atherosclerosis. Using data from the Edinburgh Artery Study, we examined the distribution of …

Fibrin D-dimer, the most commonly used clinical assay for detection of coagulation activation
and in vivo fibrin formation and lysis in circulating blood, has been associated with risks of …

Recent meta‐analyses of prospective studies have shown that plasma levels of both
fibrinogen and fibrin D‐dimer are independent predictors of ischemic heart disease …

Although D-dimer has gained widespread clinical use as a parameter for detection of in vivo
fibrin formation, the issue of standardization of D-dimer assays remains to be resolved. The …

We have previously reported that plasma fibrin D-dimer (a marker of turnover of cross-linked
fibrin) showed a strong and independent association with incident ischaemic heart disease …

Background: Fibrin‐related markers such as soluble fibrin (SF) and D‐dimer are considered
useful for the diagnosis of thrombosis. However, the evidence for diagnosis of thrombosis by …

D-dimer is a stable, terminal product of fibrin degradation in plasma. In the 1970s, Gaffney
and colleagues introduced the concept of D-dimer measurement as a biomarker of …

Fibrinogen is an independent risk factor for cardiovascular disease and both D-Dimer and
Thrombin-Antithrombin complexes may be suitable as laboratory markers of deep venous …

Increased levels of fibrin D-dimer are indicative of a hypercoagulable state, as found in
acute coronary syndromes. Few well-controlled studies have assessed D-dimers in patients …